Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Germany
Clinical trial register · Germany

Clinical Trials in Germany

Every study on the ClinicalTrials.gov registry that lists a site in Germany and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5081 matching records held by the registry are in this view. Synced 13 Nov 2026, 03:18 UTC
5081
Studies in scope
all four open statuses
2880
Recruiting now
open to new participants
985
Lead sponsors
across recruiting studies
Top sites
Berlin 11 Essen 9 Göttingen 8 Würzburg 6 Bochum 6

Trials in this register

23 of 5081 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Germany
Start
Recruiting
argenx
Observational
70
Berlin, Göttingen, Würzburg
2025-12-19
Recruiting
argenx
Phase 2
70
Berlin, Göttingen, Würzburg
2025-12-19
Recruiting
A Study of Efgartigimod IV in Participants From 12 Years to Less Than 18 Years of Age With Chronic Immune Thrombocytopenia (ITP)
NCT07194850Immune Thrombocytopenia (ITP), ITP - Immune Thrombocytopenia, ITP, Immune Thrombocytopenic Purpura
argenx
Phase 2/3
24
Berlin, Freiburg im Breisgau
2025-10-20
Recruiting
A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP
NCT06920004Chronic Inflammatory Demyelinating Polyneuropathy, CIDP, CIDP - Chronic Inflammatory Demyelinating Polyneuropathy
argenx
Phase 3
218
Berlin, Kiel
2025-08-22
Recruiting
Real-World Efgartigimod Effectiveness in CIDP: A Prospective Study
NCT07264426Chronic Inflammatory Demyelinating Polyradiculoneuropathy, CIDP, CIDP (Chronic Inflammatory Demyelinating Polyradiculoneuropathy)
argenx
Observational
200
Berlin, Bochum, Cologne, Düsseldorf, Frankfurt, Giessen, Göttingen, Hamburg
2025-08-11
Active, closed
argenx
Phase 3
631
Tübingen, Munich, Hamburg, Hanover
2025-01-15
Active, closed
argenx
Phase 3
154
Essen, Göttingen, Lübeck, Münster, Potsdam, Würzburg
2024-12-18
Active, closed
argenx
Phase 2
87
Bad Bramstedt, Lübeck, Minden, Tübingen
2024-11-11
Recruiting
argenx
Observational
680
Altenburg, Bochum, Göppingen, Göttingen, Gummersbach, Jena, Würzburg
2024-11-04
Recruiting
argenx
Phase 3
69
Dresden, Essen
2024-10-18
Active, closed
argenx
Phase 3
141
Berlin, Göttingen
2024-09-18
Recruiting
argenx
Phase 2/3
12
Essen
2024-06-28
Active, closed
argenx
Phase 3
119
Berlin, Bochum, Würzburg
2024-04-16
Active, closed
argenx
Observational
152
Berlin, Bochum, Essen
2024-02-13
Recruiting
argenx
Observational
279
Bochum
2023-11-30
Active, closed
argenx
Observational
413
Essen, Giessen, Hanover, Potsdam, Würzburg
2023-11-29
By invitation
argenx
Phase 3
240
Berlin, Hamburg, Herne, Mannheim, Tübingen, Ulm
2023-09-12
Active, closed
argenx
Phase 2
229
Bochum, Cologne, Essen, Göttingen, Kiel, Potsdam
2020-09-18
Rows per page Showing 1–23 of 23
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a German investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 15 November 2026. https://priyalifescience.com/clinical-trials-germany

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Germany and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,081 studies in total at the last sync on 13 Nov 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 23 of those studies that match the filters currently applied.

How many clinical trials are recruiting in Germany?

10 of the 23 studies on this page are recruiting new participants as of the 13 Nov 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 11 are active but closed to new participants, and 2 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase, 23 studies
PhaseStudiesRecruitingShare
Phase 38334.8%
Observational6426.1%
Phase 25121.7%
Phase 2/34217.4%

Most active sponsors

Lead sponsors with the most studies
Lead sponsorStudiesRecruiting
argenx2310

This register, in your inbox every Friday

One email a week with how many trials are recruiting in Ireland, new EMA and FDA approvals and medicine shortages, built from the same public registers as this page.

Free. Unsubscribe from any email with one click. See our privacy policy.

→

Browse trials by condition

Myasthenia Gravis (5) Generalized Myasthenia Gravis (5) gMG (4) MG (2) Multifocal Motor Neuropathy (MMN) (2) CIDP (2) CIDP - Chronic Inflammatory Demyelinating Polyneuropathy (2) Graves Disease (1) MMN (1) Congenital Myasthenic Syndrome (1) AChR-Ab Seropositive Generalized Myasthenia Gravis (1) Chronic Inflammatory Demyelinating Polyneuropathy (1) Myasthenia Gravis, Generalized (1) Immune Thrombocytopenia (ITP) (1) ITP - Immune Thrombocytopenia (1)
→

Browse trials by site location

Berlin (11) Essen (9) Göttingen (8) Würzburg (6) Bochum (6) Hamburg (4) Potsdam (3) Tübingen (3) Lübeck (2) Kiel (2) Giessen (2) Hanover (2) Dresden (2) Cologne (2) Magdeburg (1)
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.